123 related articles for article (PubMed ID: 34089858)
1. The Etonogestrel Implant in Adolescents: Factors Associated With Removal for Bothersome Bleeding in the First Year After Insertion.
Green S; Sheeder J; Richards M
J Pediatr Adolesc Gynecol; 2021 Dec; 34(6):825-831. PubMed ID: 34089858
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen for the Treatment of Etonogestrel Implant-Associated Bleeding in an Adolescent Gynecology Practice.
Friedman JC; Buyers E; Laurin J; Hampanda K; Alaniz VI
J Pediatr Adolesc Gynecol; 2022 Jun; 35(3):341-345. PubMed ID: 34780932
[TBL] [Abstract][Full Text] [Related]
3. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.
Ireland LD; Goyal V; Raker CA; Murray A; Allen RH
Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904
[TBL] [Abstract][Full Text] [Related]
4. Amenorrhea in adolescents using the etonogestrel contraceptive implant.
Tsevat D; Mercier R; Bernheimer C; Lin S; Schwartz B
Contraception; 2024 May; 133():110413. PubMed ID: 38401772
[TBL] [Abstract][Full Text] [Related]
5. Twelve-month Continuation of the Etonogestrel Implant in Adolescents With Polycystic Ovary Syndrome.
Buyers E; Sass AE; Severn CD; Pyle L; Cree-Green M
J Pediatr Adolesc Gynecol; 2021 Feb; 34(1):33-39. PubMed ID: 32919086
[TBL] [Abstract][Full Text] [Related]
6. Menstrual bleeding patterns in adolescents using etonogestrel (ENG) implant.
Deokar AM; Jackson W; Omar HA
Int J Adolesc Med Health; 2011; 23(1):75-7. PubMed ID: 21721368
[TBL] [Abstract][Full Text] [Related]
7. Etonogestrel Implants in Adolescents: Experience, Satisfaction, and Continuation.
Obijuru L; Bumpus S; Auinger P; Baldwin CD
J Adolesc Health; 2016 Mar; 58(3):284-9. PubMed ID: 26903428
[TBL] [Abstract][Full Text] [Related]
8. Early removal of etonogestrel subcutaneous contraceptive implant at a community health centre in Pretoria.
Moeti DMP; Govender I; Bongongo T
S Afr Fam Pract (2004); 2022 Jul; 64(1):e1-e6. PubMed ID: 35924618
[TBL] [Abstract][Full Text] [Related]
9. Relationship Between Etonogestrel Concentrations and Bleeding Patterns in Contraceptive Implant Users.
Lazorwitz A; Aquilante CL; Dindinger E; Harrison M; Sheeder J; Teal S
Obstet Gynecol; 2019 Oct; 134(4):807-813. PubMed ID: 31503152
[TBL] [Abstract][Full Text] [Related]
10. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
[TBL] [Abstract][Full Text] [Related]
11. Immediate postpartum etonogestrel implant: a contraception option with long-term continuation.
Wilson S; Tennant C; Sammel MD; Schreiber C
Contraception; 2014 Sep; 90(3):259-64. PubMed ID: 24993485
[TBL] [Abstract][Full Text] [Related]
12. Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial.
Vieira CS; de Nadai MN; de Melo Pereira do Carmo LS; Braga GC; Infante BF; Stifani BM; Ferriani RA; Quintana SM
Contraception; 2019 Oct; 100(4):258-263. PubMed ID: 31145885
[TBL] [Abstract][Full Text] [Related]
13. Combined oral contraceptive treatment for bleeding complaints with the etonogestrel contraceptive implant: a randomised controlled trial.
Hou MY; McNicholas C; Creinin MD
Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):361-6. PubMed ID: 27419258
[TBL] [Abstract][Full Text] [Related]
14. Six- and twelve-month documented removal rates among women electing postpartum inpatient compared to delayed or interval contraceptive implant insertions after Medicaid payment reform.
Crockett AH; Pickell LB; Heberlein EC; Billings DL; Mills B
Contraception; 2017 Jan; 95(1):71-76. PubMed ID: 27400823
[TBL] [Abstract][Full Text] [Related]
15. A contraceptive subdermal implant releasing the progestin ST-1435: ovarian function, bleeding patterns, and side effects.
Laurikka-Routti M; Haukkamaa M
Fertil Steril; 1992 Dec; 58(6):1142-7. PubMed ID: 1459263
[TBL] [Abstract][Full Text] [Related]
16. Twelve-month discontinuation of etonogestrel implant in an outpatient pediatric setting.
Berlan E; Mizraji K; Bonny AE
Contraception; 2016 Jul; 94(1):81-6. PubMed ID: 26948183
[TBL] [Abstract][Full Text] [Related]
17. Can initial vaginal bleeding patterns in etonogestrel implant users predict subsequent bleeding in the first 2 years of use?
Mansour D; Fraser IS; Edelman A; Vieira CS; Kaunitz AM; Korver T; Pong A; Lin J; Shah AK; Fox M; Rekers H; Creinin MD
Contraception; 2019 Oct; 100(4):264-268. PubMed ID: 31176688
[TBL] [Abstract][Full Text] [Related]
18. Etonogestrel implant use in women primarily choosing a combined oral contraceptive pill: A proof-of-concept trial.
Chen MJ; Hsia JK; Creinin MD
Contraception; 2018 Jun; 97(6):533-537. PubMed ID: 29496473
[TBL] [Abstract][Full Text] [Related]
19. Subdermal Contraceptive Implant Insertion Trends and Retention in Adolescents.
Tyson N; Lopez M; Merchant M; Postlethwaite D
J Pediatr Adolesc Gynecol; 2021 Jun; 34(3):348-354. PubMed ID: 33388444
[TBL] [Abstract][Full Text] [Related]
20. Assessing Weight Status in Adolescent and Young Adult Users of the Etonogestrel Contraceptive Implant.
Romano ME; Braun-Courville DK
J Pediatr Adolesc Gynecol; 2019 Aug; 32(4):409-414. PubMed ID: 30928532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]